Late toxicity predictors in high-risk prostate cancer radiotherapy using accumulated delivered dose

被引：0
|
作者：
Ong, A. [1 ,2 ]
Panettieri, V. [2 ,3 ]
Dimmock, M. [2 ,4 ]
Tuan, J. [1 ]
Tan, H. Q. [1 ]
Wright, C. [2 ]
机构：
[1] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore, Singapore
[2] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Australia
[3] Alfred Hosp, Alfred Hlth Radiat Oncol, Melbourne, Australia
[4] Keele Univ, Sch Allied Hlth Profess, Keele, Staffs, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-2118
引用
收藏
页码：S1905 / S1906
页数：2
相关论文
共 50 条
  • [1] Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose
    Ong, Ashley Li Kuan
    Knight, Kellie
    Panettieri, Vanessa
    Dimmock, Mathew
    Tuan, Jeffrey Kit Loong
    Tan, Hong Qi
    Wright, Caroline
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 25
  • [2] Using accumulated delivered dose to predict rectal toxicity in prostate radiotherapy
    Shelley, L. E. A.
    Scaife, J. E.
    Bates, A. M.
    Forman, J. R.
    Harrison, K.
    Jena, R.
    Noble, D. J.
    Parker, M. A.
    Romanchikova, M. R.
    Sutcliffe, M. P. F.
    Thomas, S. J.
    Burnet, N. G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S481 - S482
  • [3] Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer
    Ong, Ashley L. K.
    Knight, Kellie
    Panettieri, Vanessa
    Dimmock, Mathew
    Tuan, Jeffrey K. L.
    Tan, Hong Qi
    Wright, Caroline
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 23 : 97 - 102
  • [4] Radiomics with accumulated delivered dose to enhance rectal toxicity prediction in prostate cancer
    Yang, Zhuolin
    Noble, David J.
    Shelley, Leila
    Berger, Thomas
    Jena, Raj
    McLaren, Duncan B.
    Burnet, Neil G.
    Nailon, William H.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S4956 - S4959
  • [5] Late Toxicity in High-risk Prostate Cancer Treated with Androgen Suppression and Hypofractionated Intensity Modulated Radiotherapy
    Drodge, S.
    Pervez, N.
    Ghosh, S.
    Mackenzie, M.
    Yee, D.
    Mihai, A.
    Murtha, A.
    Amanie, J.
    Fallone, G.
    Pearcey, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S353 - S353
  • [6] HYPOFRACTIONATED CONCOMITANT INTENSITY-MODULATED RADIOTHERAPY BOOST FOR HIGH-RISK PROSTATE CANCER: LATE TOXICITY
    Quon, Harvey
    Cheung, Patrick C. F.
    Loblaw, D. Andrew
    Morton, Gerard
    Pang, Geordi
    Szumacher, Ewa
    Danjoux, Cyril
    Choo, Richard
    Thomas, Gillian
    Kiss, Alex
    Mamedov, Alexandre
    Deabreu, Andrea
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 898 - 905
  • [7] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    Nature Reviews Urology, 2015, 12 : 145 - 154
  • [8] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [9] Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
    Thomson, David
    Merrick, Sophie
    Swindell, Ric
    Coote, Joanna
    Kelly, Kay
    Stratford, Julie
    Wylie, James
    Cowan, Richard
    Elliott, Tony
    Logue, John
    Choudhury, Ananya
    Livsey, Jacqueline
    PROSTATE CANCER, 2012, 2012
  • [10] Clinical outcomes and late toxicity of hypofractionated intensity-modulated radiotherapy for high-risk prostate cancer.
    Wang, Michael
    Pearcey, Robert
    Pervez, Nadeem
    Yee, Don
    Mihai, Alina
    Patel, Samir
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345